Crovalimab
Product Specifications
CAS Number
1917321-26-6
Target
Complement System
Related Pathways
Immunology/Inflammation
Purity
0.9968
Bioactivity
Crovalimab (SKY59; RO7112689) is an Fc-engineered and pH-dependent humanised monoclonal antibody that binds to complement C5 and blocks its cleavage into C5a and C5b, thereby inhibiting MAC formation and intravascular haemolysis. It can rebind to the FcRn receptor under acidic pH conditions and return to the bloodstream, making it suitable for the treatment of paroxysmal nocturnal haemoglobinuria (PNH) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6356851-01 0.1 mL
TNFAIP8, NT (TNFAIP8, Tumor necrosis factor alpha-induced protein 8, Head and neck tumor and metastasis-related protein, MDC-3.13, NF-kappa-B-inducible DED-containing protein, SCC-S2, TNF-induced protein GG2-1) (MaxLight 490)
Ask
View Details 
MBS6356851-02 5x 0.1 mL
TNFAIP8, NT (TNFAIP8, Tumor necrosis factor alpha-induced protein 8, Head and neck tumor and metastasis-related protein, MDC-3.13, NF-kappa-B-inducible DED-containing protein, SCC-S2, TNF-induced protein GG2-1) (MaxLight 490)
Ask
View Details 
GTR15112663 1 Vial
Lentiviral mouse Rnd1 shRNA (UAS) - Lentiviral mouse Rnd1 shRNA (UAS) plasmid
Ask
View Details